A recently published clinical trial evaluated the impact of Ivermectin on reducing Covid-19 complications.
of ivermectin were sold in early months of the pandemic, all in efforts to treat Covid-19 infections. This was at a time where no treatment was fully understood nor developed, vaccines were in the nascent stages of investigation, and the world was seeing hospitals overrun and morgues filling trucks where hospitals had no place to hold the deceased. In parts of Brazil, over 90% of Covid-19 patients in intensive care units had taken ivermectin as their first-line therapy.
Results from a double-blind, prospective, randomized placebo-controlled clinical trial of the impact of ivermectin therapy in the early stages of Covid-19 infections compared to placebo therapy was published in this week’s. This type of study is of the highest level of significance when it comes to a research endeavor. “Double-blind” means that neither the researchers nor the participants know which intervention they are receiving.
In the group of patients who presented with acute Covid-19 infections, 679 were randomly assigned to receive ivermectin for three days, and 679 were randomly assigned to receive placebo for three days. They then looked at how many patients in these groups required treatment in either an emergency department or hospital.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Ivermectin does not prevent COVID-19 hospitalization, a new study says - Alaska Public MediaThe study serves as more evidence for what health professionals have been saying for much of the pandemic: the cow and horse de-wormer shouldn’t be used to treat COVID.
Weiterlesen »
Study finds drug ivermectin failed as COVID-19 treatment, surged in popularity during pandemicThe antiparasitic drug jumped in notoriety amid the pandemic after reports of its growing use and high profile people discussing its use as an alternative treatment for coronavirus infection despite a lack of strong research for its use in treating the virus in humans.
Weiterlesen »
Ivermectin Doesn’t Help Treat COVID-19, Large Study FindsIvermectin showed no signs of combating COVID-19 or reducing patients’ risk of hospitalization, according to results from a large clinical trial.
Weiterlesen »
Ivermectin does not prevent COVID-19 hospitalization, a new study saysThe study serves as more evidence for what health professionals have been saying for much of the pandemic: the cow and horse de-wormer shouldn’t be used to treat COVID.
Weiterlesen »
Ivermectin does not prevent COVID-19 hospitalization, study findsThe study was published Wednesday in the New England Journal of Medicine after researchers in Brazil studied more than 1,300 patients, half of which received ivermectin and the other half a placebo.
Weiterlesen »
Ivermectin Did Nothing To Help COVID-19 Patients, Large Study Says“If there are active treatments, it is better to use those agents than agents that we wish worked,' the New England Journal of Medicine's deputy editor said.
Weiterlesen »